Background: Given the high prevalence of clinically relevant premenstrual symptoms and the associated impairment, there is a need for effective treatments. Initial evidence suggests cognitive-behavioural therapy (CBT) as an effective treatment for premenstrual dysphoric disorder (PMDD). The aim of the current randomized clinical trial was to evaluate an Internet-based CBT (iCBT) to reduce the burden of PMDD. Methods: In all, 174 women with PMDD were recruited via newspaper articles, flyers, and social media. They were randomized to a treatment group (TG; n = 86) or waitlist control group (CG; n = 88). Women of the TG received an 8-week therapist-guided iCBT. Data were assessed before and after treatment/waiting, and 6 months after intervention with prospective symptom diaries and questionnaires in the premenstrual phase. Treatment effects and moderators were analysed using hierarchical linear modelling. Results: Significant time × group interaction effects on functional impairment and psychological impairment, impact on everyday life, symptom intensity, and symptom disability in favour of the TG indicated the efficacy of the treatment. Follow-up assessments demonstrated treatment effects to be stable until 6 months after treatment. Additionally, significant interactions with moderator variables were found. In the TG, higher levels of active coping and lower levels of support-seeking coping were associated with stronger improvement in interference in everyday life and symptom intensity. In addition, lower levels of perceived stress were associated with stronger improvement in functional impairment. Conclusion: The iCBT was highly effective in reducing the burden of PMDD. It appears to be particularly important to address coping styles and stress management in the treatment.

1.
Campagne
DM
,
Campagne
G
.
The premenstrual syndrome revisited
.
Eur J Obstet Gynecol Reprod Biol
.
2007
Jan
;
130
(
1
):
4
17
.
[PubMed]
0301-2115
2.
Appleton
SM
.
Premenstrual Syndrome: Evidence-based Evaluation and Treatment
.
Clin Obstet Gynecol
.
2018
Mar
;
61
(
1
):
52
61
.
[PubMed]
1532-5520
3.
American Psychiatric Association
.
Diagnostic and statistical manual of mental disorders (DSM-5)
.
Washington (DC)
:
American Psychiatric Publishing
;
2013
.
4.
American Psychiatric Association
.
Diagnostic and statistical manual of mental disorders.
Fifth edition. DSM-5. Washington, D.C.: APA;
2013
.
5.
Halbreich
U
,
Borenstein
J
,
Pearlstein
T
,
Kahn
LS
.
The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD)
.
Psychoneuroendocrinology
.
2003
Aug
;
28
Suppl 3
:
1
23
.
[PubMed]
0306-4530
6.
Potter
J
,
Bouyer
J
,
Trussell
J
,
Moreau
C
.
Premenstrual syndrome prevalence and fluctuation over time: results from a French population-based survey
.
J Womens Health (Larchmt)
.
2009
Jan-Feb
;
18
(
1
):
31
9
.
[PubMed]
1540-9996
7.
Pilver
CE
,
Libby
DJ
,
Hoff
RA
.
Premenstrual dysphoric disorder as a correlate of suicidal ideation, plans, and attempts among a nationally representative sample
.
Soc Psychiatry Psychiatr Epidemiol
.
2013
Mar
;
48
(
3
):
437
46
.
[PubMed]
0933-7954
8.
Chawla
A
,
Swindle
R
,
Long
S
,
Kennedy
S
,
Sternfeld
B
.
Premenstrual dysphoric disorder: is there an economic burden of illness?
Med Care
.
2002
Nov
;
40
(
11
):
1101
12
.
[PubMed]
0025-7079
9.
Hunter
MS
,
Ussher
JM
,
Browne
SJ
,
Cariss
M
,
Jelley
R
,
Katz
M
.
A randomized comparison of psychological (cognitive behavior therapy), medical (fluoxetine) and combined treatment for women with premenstrual dysphoric disorder
.
J Psychosom Obstet Gynaecol
.
2002
Sep
;
23
(
3
):
193
9
.
[PubMed]
0167-482X
10.
Marjoribanks
J
,
Brown
J
,
O’Brien
PM
,
Wyatt
K
.
Selective serotonin reuptake inhibitors for premenstrual syndrome
.
Cochrane Database Syst Rev
.
2013
Jun
;(
6
):
CD001396
.
[PubMed]
1469-493X
11.
Lete
I
,
Lapuente
O
.
Contraceptive options for women with premenstrual dysphoric disorder: current insights and a narrative review
.
Open Access J Contracept
.
2016
Aug
;
7
:
117
25
.
[PubMed]
1179-1527
12.
Naheed
B
,
Uthman
OA
,
O'Mahony
F
,
Kuiper
JH
,
O'Brien
PMS
. Gonadotropin‐releasing hormone (GnRH) analogues for premenstrual syndrome (PMS). Cochrane Database of Systematic Reviews.
2014
(10).
13.
Pearlstein
TB
,
Bellew
KM
,
Endicott
J
,
Steiner
M
.
Paroxetine Controlled Release for Premenstrual Dysphoric Disorder: Remission Analysis Following a Randomized, Double-Blind, Placebo-Controlled Trial
.
Prim Care Companion J Clin Psychiatry
.
2005
;
7
(
2
):
53
60
.
[PubMed]
1523-5998
14.
Sundström-Poromaa
I
,
Bixo
M
,
Björn
I
,
Nordh
O
.
Compliance to antidepressant drug therapy for treatment of premenstrual syndrome
.
J Psychosom Obstet Gynaecol
.
2000
Dec
;
21
(
4
):
205
11
.
[PubMed]
0167-482X
15.
Shobeiri
F
,
Araste
FE
,
Ebrahimi
R
,
Jenabi
E
,
Nazari
M
.
Effect of calcium on premenstrual syndrome: A double-blind randomized clinical trial
.
Obstet Gynecol Sci
.
2017
Jan
;
60
(
1
):
100
5
.
[PubMed]
2287-8572
16.
Verkaik
S
,
Kamperman
AM
,
van Westrhenen
R
,
Schulte
PF
.
The treatment of premenstrual syndrome with preparations of Vitex agnus castus: a systematic review and meta-analysis
.
Am J Obstet Gynecol
.
2017
Aug
;
217
(
2
):
150
66
.
[PubMed]
0002-9378
17.
Chocano-Bedoya
PO
,
Bertone-Johnson
ER
. Premenstrual Syndrome. In:
Goldman
M
,
Troisi
R
,
Rexrode
K
, editors
.
Women Health. 2nd
.
Amsterdam
:
Elsevier
;
2013
. pp.
179
91
.
18.
Bluth
K
,
Gaylord
S
,
Nguyen
K
,
Bunevicius
A
,
Girdler
S
.
Mindfulness-based Stress Reduction as a Promising Intervention for Amelioration of Premenstrual Dysphoric Disorder Symptoms
.
Mindfulness (N Y)
.
2015
Dec
;
6
(
6
):
1292
302
.
[PubMed]
1868-8527
19.
Goodale
IL
,
Domar
AD
,
Benson
H
.
Alleviation of premenstrual syndrome symptoms with the relaxation response
.
Obstet Gynecol
.
1990
Apr
;
75
(
4
):
649
55
.
[PubMed]
0029-7844
20.
Kroll-Desrosiers
AR
,
Ronnenberg
AG
,
Zagarins
SE
,
Houghton
SC
,
Takashima-Uebelhoer
BB
,
Bertone-Johnson
ER
.
Recreational Physical Activity and Premenstrual Syndrome in Young Adult Women: A Cross-Sectional Study
.
PLoS One
.
2017
Jan
;
12
(
1
):
e0169728
.
[PubMed]
1932-6203
21.
Busse
JW
,
Montori
VM
,
Krasnik
C
,
Patelis-Siotis
I
,
Guyatt
GH
.
Psychological intervention for premenstrual syndrome: a meta-analysis of randomized controlled trials
.
Psychother Psychosom
.
2009
;
78
(
1
):
6
15
.
[PubMed]
0033-3190
22.
Kleinstäuber
M
,
Witthöft
M
,
Hiller
W
.
Cognitive-behavioral and pharmacological interventions for premenstrual syndrome or premenstrual dysphoric disorder: a meta-analysis
.
J Clin Psychol Med Settings
.
2012
Sep
;
19
(
3
):
308
19
.
[PubMed]
1068-9583
23.
Hunter
MS
,
Ussher
JM
,
Cariss
M
,
Browne
S
,
Jelley
R
,
Katz
M
.
Medical (fluoxetine) and psychological (cognitive-behavioural therapy) treatment for premenstrual dysphoric disorder: a study of treatment processes
.
J Psychosom Res
.
2002
Sep
;
53
(
3
):
811
7
.
[PubMed]
0022-3999
24.
Facchinetti
F
,
Tarabusi
M
,
Nappi
G
.
Premenstrual syndrome and anxiety disorders: a psychobiological link
.
Psychother Psychosom
.
1998
;
67
(
2
):
57
60
.
[PubMed]
0033-3190
25.
Janda
C
,
Kues
JN
,
Kleinstaeuber
M
,
Weise
C
. A Therapeutic Approach to Premenstrual Syndrome (PMS): Modularized Treatment Program. Verhaltenstherapie.
2015
;25.
26.
Andersson
G
.
Internet-Delivered Psychological Treatments
.
Annu Rev Clin Psychol
.
2016
;
12
(
1
):
157
79
.
[PubMed]
1548-5943
27.
Josephine
K
,
Josefine
L
,
Philipp
D
,
David
E
,
Harald
B
.
Internet- and mobile-based depression interventions for people with diagnosed depression: A systematic review and meta-analysis
.
J Affect Disord
.
2017
Dec
;
223
:
28
40
.
[PubMed]
0165-0327
28.
Carlbring
P
,
Andersson
G
,
Cuijpers
P
,
Riper
H
,
Hedman-Lagerlöf
E
.
Internet-based vs. face-to-face cognitive behavior therapy for psychiatric and somatic disorders: an updated systematic review and meta-analysis
.
Cogn Behav Ther
.
2018
Jan
;
47
(
1
):
1
18
.
[PubMed]
1650-6073
29.
Baumeister
H
,
Reichler
L
,
Munzinger
M
,
Lin
J
.
The impact of guidance on Internet-based mental health interventions— A systematic review
.
Internet Interv
.
2014
;
1
(
4
):
205
15
. 2214-7829
30.
Zagorscak
P
,
Heinrich
M
,
Sommer
D
,
Wagner
B
,
Knaevelsrud
C
.
Benefits of Individualized Feedback in Internet-Based Interventions for Depression: A Randomized Controlled Trial
.
Psychother Psychosom
.
2018
;
87
(
1
):
32
45
.
[PubMed]
0033-3190
31.
Fontana
AM
,
Palfai
TG
.
Psychosocial factors in premenstrual dysphoria: stressors, appraisal, and coping processes
.
J Psychosom Res
.
1994
Aug
;
38
(
6
):
557
67
.
[PubMed]
0022-3999
32.
Ditzen
B
,
Nussbeck
F
,
Drobnjak
S
,
Spoerri
C
,
Wueest
D
,
Ehlert
U
.
A German DSM-IV-TR-based questionnaire for the screening of premenstrual symptoms
.
Z Klin Psychol Psychother
.
2011
;
40
(
3
).1616-3443
33.
Kues
JN
,
Janda
C
,
Kleinstäuber
M
,
Weise
C
.
Internet-based cognitive behavioural self-help for premenstrual syndrome: study protocol for a randomised controlled trial
.
Trials
.
2014
Dec
;
15
(
1
):
472
.
[PubMed]
1745-6215
34.
van Ballegooijen
W
,
Cuijpers
P
,
van Straten
A
,
Karyotaki
E
,
Andersson
G
,
Smit
JH
, et al
Adherence to Internet-based and face-to-face cognitive behavioural therapy for depression: a meta-analysis
.
PLoS One
.
2014
Jul
;
9
(
7
):
e100674
.
[PubMed]
1932-6203
35.
Vlaescu
G
,
Alasjö
A
,
Miloff
A
,
Carlbring
P
,
Andersson
G
.
Features and functionality of the Iterapi platform for internet-based psychological treatment
.
Internet Interv
.
2016
Oct
;
6
:
107
14
.
[PubMed]
2214-7829
36.
Kues
JN
,
Janda
C
,
Kleinstäuber
M
,
Weise
C
.
How to measure the impact of premenstrual symptoms? Development and validation of the German PMS-Impact Questionnaire
.
Women Health
.
2016
Oct
;
56
(
7
):
807
26
.
[PubMed]
0363-0242
37.
Janda
C
,
Kues
JN
,
Andersson
G
,
Kleinstäuber
M
,
Weise
C
.
A symptom diary to assess severe premenstrual syndrome and premenstrual dysphoric disorder
.
Women Health
.
2017
Aug
;
57
(
7
):
837
54
.
[PubMed]
0363-0242
38.
Tait
RC
,
Chibnall
JT
,
Krause
S
.
The Pain Disability Index: psychometric properties
.
Pain
.
1990
Feb
;
40
(
2
):
171
82
.
[PubMed]
0304-3959
39.
Mewes
R
,
Rief
W
,
Stenzel
N
,
Glaesmer
H
,
Martin
A
,
Brähler
E
.
What is “normal” disability? An investigation of disability in the general population
.
Pain
.
2009
Mar
;
142
(
1-2
):
36
41
.
[PubMed]
0304-3959
40.
Jacobson
NS
,
Truax
P
.
Clinical significance: a statistical approach to defining meaningful change in psychotherapy research
.
J Consult Clin Psychol
.
1991
Feb
;
59
(
1
):
12
9
.
[PubMed]
0022-006X
41.
Kaiser
G
,
Kues
JN
,
Kleinstäuber
M
,
Andersson
G
,
Weise
C
. Methods for coping with premenstrual change: development and validation of the German Premenstrual Change Coping Inventory (PMS-Cope). Women Health.
2017
:null-null.
42.
Cohen
S.
Perceived stress scale.
1994
.
43.
Raudenbush
SW
,
Bryk
AS
,
Congdon
R
.
HLM 7.03 for Windows
[
Computer software
]
Skokie (IL)
:
Scientific Software International, Inc.
;
2017
.
44.
Raudenbush
SW
,
Bryk
AS
.
Hierarchical Linear Models: Applications and Data Analysis Methods
. 2nd ed.
Newbury Park (CA)
:
Sage
;
2002
.
45.
Snijders
TA
,
Bosker
RJ
.
Multilevel analysis: An introduction to basic and advanced multilevel modeling
.
Thousand Oaks (CA)
:
Sage Publishing
;
2012
.
46.
Cohen
J
.
A power primer
.
Psychol Bull
.
1992
Jul
;
112
(
1
):
155
9
.
[PubMed]
0033-2909
47.
SPSS I. IBM SPSS Statistics
.
Version
. 19.0.0 ed.
New York (NY)
:
IBM
;
2010
.
48.
Lustyk
MKB
,
Gerrish
WG
,
Shaver
S
,
Keys
SL
.
Cognitive-behavioral therapy for premenstrual syndrome and premenstrual dysphoric disorder: a systematic review.
Arch Womens Ment Health.
2009
;12(2).
49.
Morse
G.
Positively reframing perceptions of the menstrual cycle among women with premenstrual syndrome.
Journal of obstetric, gynecologic, and neonatal nursing : JOGNN / NAACOG.
1999
;28(2).
50.
Kirkby
RJ
.
Changes in premenstrual symptoms and irrational thinking following cognitive-behavioral coping skills training
.
J Consult Clin Psychol
.
1994
Oct
;
62
(
5
):
1026
32
.
[PubMed]
0022-006X
51.
Ussher
JM
,
Perz
J
.
Evaluation of the relative efficacy of a couple cognitive-behaviour therapy (CBT) for Premenstrual Disorders (PMDs), in comparison to one-to-one CBT and a wait list control: A randomized controlled trial
.
PLoS One
.
2017
Apr
;
12
(
4
):
e0175068
.
[PubMed]
1932-6203
52.
De Ronchi
D
,
Muro
A
,
Marziani
A
,
Rucci
P
.
Personality disorders and depressive symptoms in late luteal phase dysphoric disorder
.
Psychother Psychosom
.
2000
;
69
(
1
):
27
34
.
[PubMed]
0033-3190
53.
van Beugen
S
,
Ferwerda
M
,
Hoeve
D
,
Rovers
MM
,
Spillekom-van Koulil
S
,
van Middendorp
H
, et al
Internet-based cognitive behavioral therapy for patients with chronic somatic conditions: a meta-analytic review
.
J Med Internet Res
.
2014
Mar
;
16
(
3
):
e88
.
[PubMed]
1438-8871
54.
Woda
A
,
Picard
P
,
Dutheil
F
.
Dysfunctional stress responses in chronic pain
.
Psychoneuroendocrinology
.
2016
Sep
;
71
:
127
35
.
[PubMed]
0306-4530
55.
Huguet
A
,
Miller
A
,
Kisely
S
,
Rao
S
,
Saadat
N
,
McGrath
PJ
.
A systematic review and meta-analysis on the efficacy of Internet-delivered behavioral activation
.
J Affect Disord
.
2018
Aug
;
235
:
27
38
.
[PubMed]
0165-0327
56.
Bolger
N
,
Amarel
D
.
Effects of social support visibility on adjustment to stress: experimental evidence
.
J Pers Soc Psychol
.
2007
Mar
;
92
(
3
):
458
75
.
[PubMed]
0022-3514
57.
Ang
S
,
Malhotra
R
.
Association of received social support with depressive symptoms among older males and females in Singapore: is personal mastery an inconsistent mediator?
Soc Sci Med
.
2016
Mar
;
153
:
165
73
.
[PubMed]
0277-9536
58.
Cole
JI
,
Suman
M
,
Schramm
P
,
Zhou
L
.
The World Internet Project International Report
.
USC Annenberg School Center for the Digital Future, University of South California
;
2017
.
59.
Guidi
J
,
Brakemeier
EL
,
Bockting
CL
,
Cosci
F
,
Cuijpers
P
,
Jarrett
RB
, et al
Methodological Recommendations for Trials of Psychological Interventions
.
Psychother Psychosom
.
2018
;
87
(
5
):
276
84
.
[PubMed]
0033-3190
60.
Sander
L
,
Rausch
L
,
Baumeister
H
.
Effectiveness of Internet-Based Interventions for the Prevention of Mental Disorders: A Systematic Review and Meta-Analysis
.
JMIR Ment Health
.
2016
Aug
;
3
(
3
):
e38
.
[PubMed]
2368-7959
61.
Chrisler
JC
,
Caplan
P
.
The strange case of Dr. Jekyll and Ms. Hyde: how PMS became a cultural phenomenon and a psychiatric disorder
.
Annu Rev Sex Res
.
2002
;
13
(
1
):
274
306
.
[PubMed]
1053-2528
62.
Andersson
G
,
Titov
N
.
Advantages and limitations of Internet-based interventions for common mental disorders
.
World Psychiatry
.
2014
Feb
;
13
(
1
):
4
11
.
[PubMed]
1723-8617
63.
Chrisler
JC
.
Leaks, Lumps, and Lines: Stigma and Women’s Bodies
.
Psychol Women Q
.
2011
;
35
(
2
):
202
14
. 0361-6843
64.
Kauer
SD
,
Mangan
C
,
Sanci
L
.
Do online mental health services improve help-seeking for young people? A systematic review
.
J Med Internet Res
.
2014
Mar
;
16
(
3
):
e66
.
[PubMed]
1438-8871
65.
Jasper
K
,
Weise
C
,
Conrad
I
,
Andersson
G
,
Hiller
W
,
Kleinstäuber
M
.
The working alliance in a randomized controlled trial comparing Internet-based self-help and face-to-face cognitive behavior therapy for chronic tinnitus
.
Internet Interv
.
2014
;
1
(
2
):
49
57
. 2214-7829
66.
Heinrich
S
,
Rozental
A
,
Carlbring
P
,
Andersson
G
,
Cotter
K
,
Weise
C
.
Treating tinnitus distress via the Internet: A mixed methods approach of what makes patients seek help and stay motivated during Internet-based cognitive behavior therapy
.
Internet Interv
.
2016
May
;
4
(
Part 2
):
120
30
.
[PubMed]
2214-7829
67.
Eriksson
MC
,
Kivi
M
,
Hange
D
,
Petersson
EL
,
Ariai
N
,
Häggblad
P
, et al
Long-term effects of Internet-delivered cognitive behavioral therapy for depression in primary care - the PRIM-NET controlled trial
.
Scand J Prim Health Care
.
2017
Jun
;
35
(
2
):
126
36
.
[PubMed]
0281-3432
68.
Hedman
E
,
Ljótsson
B
,
Kaldo
V
,
Hesser
H
,
El Alaoui
S
,
Kraepelien
M
, et al
Effectiveness of Internet-based cognitive behaviour therapy for depression in routine psychiatric care
.
J Affect Disord
.
2014
Feb
;
155
:
49
58
.
[PubMed]
0165-0327
69.
Folker
AP
,
Mathiasen
K
,
Lauridsen
SM
,
Stenderup
E
,
Dozeman
E
,
Folker
MP
.
Implementing internet-delivered cognitive behavior therapy for common mental health disorders: A comparative case study of implementation challenges perceived by therapists and managers in five European internet services
.
Internet Interv
.
2018
Feb
;
11
:
60
70
.
[PubMed]
2214-7829
70.
Kaiser
G
,
Schormann
A
,
Kues
JN
,
Weise
C
.
Knowledge about Positive Premenstrual Changes and Somatosensory Amplification Increase the Report of Positive Premenstrual Changes: An Experimental Study
.
Psychother Psychosom
.
2018
;
87
(
4
):
237
9
.
[PubMed]
0033-3190
71.
Kues
JN
,
Janda
C
,
Krzikalla
C
,
Andersson
G
,
Weise
C
.
The effect of manipulated information about premenstrual changes on the report of positive and negative premenstrual changes
.
Women Health
.
2018
Jan
;
58
(
1
):
16
37
.
[PubMed]
0363-0242
72.
Chaturvedi
SK
,
Chandra
PS
,
Issac
MK
,
Sudarshan
CY
,
Beena
MB
,
Sarmukkadam
SB
, et al
Premenstrual experiences: the four profiles and factorial patterns
.
J Psychosom Obstet Gynaecol
.
1993
Sep
;
14
(
3
):
223
35
.
[PubMed]
0167-482X
73.
van Beugen
S
,
Ferwerda
M
,
Spillekom-van Koulil
S
,
Smit
JV
,
Zeeuwen-Franssen
ME
,
Kroft
EB
, et al
Tailored Therapist-Guided Internet-Based Cognitive Behavioral Treatment for Psoriasis: A Randomized Controlled Trial
.
Psychother Psychosom
.
2016
;
85
(
5
):
297
307
.
[PubMed]
0033-3190
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.